Table 6. Comparison in sclerostin with different fungal infections in CD patients.
|
P value |
Patients group (Mean ±SE) |
Control group (Mean ±SE) |
Fungus types |
|
*0.044 |
0.274 ±0.18 |
0.00 ±0.00 |
Candida albicans |
|
0.252 N.S |
0.00 ±0.00 |
0.0175 ±0.01 |
Candida glabrata |
|
0 N.S |
0.00 ±0.00 |
0.00 ±0.00 |
Candida tropicalis |
*Significant at probability level p≤0.05. N.S Non-significant at probability p>0.05